In 2014, Medicare spent $286 million

on 10,000 New York patients who took the Hepatitis C drug Sovaldi, which costs $84,000-per-patient annually. In 2013, Medicare spent $286 million nation-wide for earlier generation medications for Hepatitis C, according to federal data.

Source: "Federal spending on Hepatitis C drugs soared in 2014," Capital New York, April 3, 2015, http://www.capitalnewyork.com/article/albany/2015/04/8565397/federal-spending-hepatitis-c-drugs-soared-2014